{"id":3676,"date":"2016-06-22T15:54:20","date_gmt":"2016-06-22T15:54:20","guid":{"rendered":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?p=3676"},"modified":"2016-06-22T15:54:20","modified_gmt":"2016-06-22T15:54:20","slug":"arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen","status":"publish","type":"post","link":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/","title":{"rendered":"Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen"},"content":{"rendered":"<p>AMB 2016, 50,\u00a047a Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen Fazit: Loperamid kann in extrem hoher Dosierung und\/oder in Kombination mit anderen Arzneimitteln (z.B. Verapamil, Nifedipin, Chinin, Chinidin, Ciclosporin oder Clarithromycin) Effekte auf das ZNS und den Herzrhythmus haben. Letztere sind potenziell letal. In den USA hat in den vergangenen Jahren der Loperamid-Missbrauch unter Opioid-Abh\u00e4ngigen stark zugenommen. [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AMB 2016, 50,\u00a047a Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen Fazit: Loperamid kann in extrem hoher Dosierung und\/oder in Kombination mit anderen Arzneimitteln (z.B. Verapamil, Nifedipin, Chinin, Chinidin, Ciclosporin oder Clarithromycin) Effekte auf das ZNS und den Herzrhythmus haben. Letztere sind potenziell letal. In den USA hat in den vergangenen Jahren der Loperamid-Missbrauch unter Opioid-Abh\u00e4ngigen stark zugenommen. [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[1],"tags":[1654,121,1236,2412,1799,1959,1238,122],"class_list":["post-3676","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-herz-kreislauf-stillstand","tag-herzrhythmusstoerungen","tag-herzstillstand","tag-kardiotoxizitaet","tag-kreislaufstillstand","tag-loperamid","tag-reanimation","tag-rhythmusstoerungen"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen<\/title>\n<meta name=\"description\" content=\"Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen -- UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken --&gt;\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen\" \/>\n<meta property=\"og:description\" content=\"Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen -- UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken --&gt;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/\" \/>\n<meta property=\"og:site_name\" content=\"Der Arzneimittelbrief\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/derarzneimittelbrief.de\" \/>\n<meta property=\"article:published_time\" content=\"2016-06-22T15:54:20+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg\" \/>\n<meta name=\"author\" content=\"Hiwot\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Hiwot\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\\\/\"},\"author\":{\"name\":\"Hiwot\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a430337ae39f7e856414023e2397b13c\"},\"headline\":\"Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen\",\"datePublished\":\"2016-06-22T15:54:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\\\/\"},\"wordCount\":193,\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/GPSP_Banner_AMB_01_2013.jpg\",\"keywords\":[\"Herz-Kreislauf-Stillstand\",\"Herzrhythmusst\u00f6rungen\",\"Herzstillstand\",\"Kardiotoxizit\u00e4t\",\"Kreislaufstillstand\",\"Loperamid\",\"Reanimation\",\"Rhythmusst\u00f6rungen\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\\\/\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\\\/\",\"name\":\"Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/GPSP_Banner_AMB_01_2013.jpg\",\"datePublished\":\"2016-06-22T15:54:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a430337ae39f7e856414023e2397b13c\"},\"description\":\"Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen -- UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\\\/#primaryimage\",\"url\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/GPSP_Banner_AMB_01_2013.jpg\",\"contentUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/GPSP_Banner_AMB_01_2013.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\",\"name\":\"Der Arzneimittelbrief\",\"description\":\"Unabh\u00e4ngige Arzneimittelinformationen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a430337ae39f7e856414023e2397b13c\",\"name\":\"Hiwot\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4de5c07508f9b9a25fb2354c5c40a6bfb18ed47290c54c62a986b86e944e1dd1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4de5c07508f9b9a25fb2354c5c40a6bfb18ed47290c54c62a986b86e944e1dd1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4de5c07508f9b9a25fb2354c5c40a6bfb18ed47290c54c62a986b86e944e1dd1?s=96&d=mm&r=g\",\"caption\":\"Hiwot\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen","description":"Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen -- UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/","og_locale":"de_DE","og_type":"article","og_title":"Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen","og_description":"Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen -- UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->","og_url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/","og_site_name":"Der Arzneimittelbrief","article_publisher":"http:\/\/www.facebook.com\/derarzneimittelbrief.de","article_published_time":"2016-06-22T15:54:20+00:00","og_image":[{"url":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg","type":"","width":"","height":""}],"author":"Hiwot","twitter_misc":{"Verfasst von":"Hiwot","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/#article","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/"},"author":{"name":"Hiwot","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a430337ae39f7e856414023e2397b13c"},"headline":"Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen","datePublished":"2016-06-22T15:54:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/"},"wordCount":193,"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/#primaryimage"},"thumbnailUrl":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg","keywords":["Herz-Kreislauf-Stillstand","Herzrhythmusst\u00f6rungen","Herzstillstand","Kardiotoxizit\u00e4t","Kreislaufstillstand","Loperamid","Reanimation","Rhythmusst\u00f6rungen"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/","name":"Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/#primaryimage"},"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/#primaryimage"},"thumbnailUrl":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg","datePublished":"2016-06-22T15:54:20+00:00","author":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a430337ae39f7e856414023e2397b13c"},"description":"Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen -- UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->","breadcrumb":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/#primaryimage","url":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg","contentUrl":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/arrhythmierisiko-durch-loperamid-missbrauch-bei-opioid-abhaengigen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/"},{"@type":"ListItem","position":2,"name":"Arrhythmierisiko durch Loperamid-Missbrauch bei Opioid-Abh\u00e4ngigen"}]},{"@type":"WebSite","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/","name":"Der Arzneimittelbrief","description":"Unabh\u00e4ngige Arzneimittelinformationen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a430337ae39f7e856414023e2397b13c","name":"Hiwot","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/4de5c07508f9b9a25fb2354c5c40a6bfb18ed47290c54c62a986b86e944e1dd1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4de5c07508f9b9a25fb2354c5c40a6bfb18ed47290c54c62a986b86e944e1dd1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4de5c07508f9b9a25fb2354c5c40a6bfb18ed47290c54c62a986b86e944e1dd1?s=96&d=mm&r=g","caption":"Hiwot"}}]}},"_links":{"self":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/3676","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/comments?post=3676"}],"version-history":[{"count":3,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/3676\/revisions"}],"predecessor-version":[{"id":3679,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/3676\/revisions\/3679"}],"wp:attachment":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/media?parent=3676"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/categories?post=3676"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/tags?post=3676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}